Philip P. Connell to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Philip P. Connell has written about Drug Resistance, Neoplasm.
Connection Strength
0.236
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.157
-
A chemical compound that stimulates the human homologous recombination protein RAD51. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15848-53.
Score: 0.064
-
The Yin and Yang of treating BRCA-deficient tumors. Cell. 2008 Mar 21; 132(6):919-20.
Score: 0.015